K Number
K052820
Device Name
PARAPOST PARACORE AUTOMIX 5ML
Date Cleared
2006-01-09

(97 days)

Product Code
Regulation Number
872.3690
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
ParaPost ParaCore automix 5ml is indicated for core build-ups and cementation of posts
Device Description
Not Found
More Information

Not Found

Not Found

No
The 510(k) summary describes a dental material (core build-up and post cementation) and contains no mention of AI, ML, image processing, or any other technology typically associated with AI/ML in medical devices.

No
The device is described as a material for core build-ups and cementation of posts, which is a dental material and not a device intended to treat or prevent a disease or condition.

No
The device is described as being for "core build-ups and cementation of posts," which are restorative dental procedures, not diagnostic ones.

No

The provided text describes a dental material (core build-up and cementation of posts) and does not mention any software component.

Based on the provided information, the ParaPost ParaCore automix 5ml is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "for core build-ups and cementation of posts." This describes a dental procedure performed directly on a patient's tooth, not a test performed on a sample taken from the body to diagnose a condition.
  • Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Providing diagnostic information about a disease or condition
    • Using reagents or assays

Therefore, the ParaPost ParaCore automix 5ml is a dental material used in a restorative procedure, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

  • ParaPost ParaCore automix 5ml is indicated for core build-ups and cementation of posts

Product codes

EBF

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.3690 Tooth shade resin material.

(a)
Identification. Tooth shade resin material is a device composed of materials such as bisphenol-A glycidyl methacrylate (Bis-GMA) intended to restore carious lesions or structural defects in teeth.(b)
Classification. Class II.

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features the department's name in a circular arrangement around a symbol. The symbol consists of a stylized caduceus, which is a traditional symbol of medicine, with three figures representing health and well-being.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

2006 JAN 9

Coltene/Whaledent AG C/O Mr. II.J. Vogelstein Consultant Henry J. Vogelstein 1349 Lexington Avenue New York, New York 10128

Re: K052820

Trade/Device Name: ParaPost ParaCore Automix 5ml Regulation Number: 872.3690 Regulation Name: Tooth Shade Resin Material Regulatory Class: II Product Code: EBF Dated: December 9, 2005 Received: December 12, 2005

Dear Mr. Vogelstein:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Page 2 - Mr. Vogelstein

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Chiu Lin, Ph.D.

Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Image /page/2/Picture/0 description: The image contains the words "coltène whaledent" in a bold, sans-serif font. The word "coltène" is positioned above "whaledent". The text is black against a white background. The right side of the image is cut off.

Coltène/Whaledent AG 510(k) Submission ParaPost ParaCore automix 5ml Indications for use

Indications for use

Kosz8zo 510(k) Number (if known): n/k

Device Name:

ParaPost ParaCore automix 5ml

Indications for use:

  • ParaPost ParaCore automix 5ml is indicated for core build-ups and cementation of posts

X Prescription Use: _ (21 CFR Part 801 Subpart D)

Over-the Counter Use: _ (21 CFR Part 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

and/or

Concurrence of CDRH, Office of Device Evaluation (ODE)

Susan Punner

Sydney General Hosp

Edwards, Lifesci Devices

K052820